16 November 2023
The Nuffield Department of Primary Care Health Sciences wins an NIHR award for a new HealthTech Research Centre (HRC) to explore innovative Health Technology to enhance community and primary care.
31 October 2023
Oxford’s early detection research was featured at this annual event.
23 October 2023
SerenOx Africa, led by Professor Anna Schuh, aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility also aims to provide early cancer detection for high-risk patients.
6 October 2023
An agreement between Satisfai Health Inc and the University of Oxford will progress the automated assessment of Barrett’s oesophagus with the aim of determining patients most at risk of developing oesophageal cancer.
25 September 2023
Congratulations to James Chettle, Masato Inoue and Eoghan Mulholland who have been awarded OxCODE funds to attend this year’s Early Detection of Cancer conference in London.
21 September 2023
Oxford’s first precision prevention cancer trial in people with Li Fraumeni Syndrome will also shed light on the mechanisms of cancer development in the general population
10 September 2023
A study led by the Mead Group has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant blood stem cells, shedding light on the progression of leukaemia.
31 August 2023
Congratulations to James McCullagh, Monica Olcina, Bethan Psaila, and their collaborators who have been awarded funding in the fourth round of the OxCODE Funding Scheme.
24 August 2023
A team of researchers led by Professor Julia Hippisley-Cox have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.
Double funding success to improve detection and risk classification of myeloproliferative neoplasms (MPNs)
21 August 2023
Blood Cancer UK and Cancer Research UK recognise the need and impact of artificial intelligence approaches developed by Professor Daniel Royston and Professor Jens Rittscher for early detection and assessment of these blood cancers.
Identification of a molecular signature that correlates with patient prognosis in SETD2-mutated cancers
21 August 2023
In a pan-cancer analysis spanning 24 different cancer types, researchers shed light on the relationship between SETD2, DNA methylation and cancer development.
15 August 2023
A new study from Professor Julia Hippisley-Cox and colleagues offers hope for the earlier detection of oesophageal cancer
7 August 2023
The National Institute for Health and Care Research (NIHR) has announced a major investment in its Policy Research Units (PRUs). Researchers in the Nuffield Department of Primary Care Health Sciences at Oxford will play a key role in a new Unit focusing on the early detection of cancer.
Oxford to launch UK’s first trials unit dedicated to conducting precision prevention and early detection studies
17 July 2023
Oxford researchers have been given a £1 million boost to support their strategy of developing cancer prevention treatments and early diagnostic tools for people at high risk of cancer.
12 June 2023
David Hunter, Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health and OxCODE Associate Director, has been appointed as a Companion of the Order of Australia in the Australian King’s Birthday Honours List.
2 June 2023
An NHS trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms, in England or Wales. The test also correctly identified the original site of cancer in 85% of those cases.
29 May 2023
1000 patients have been recruited for the prospective Pearl study within the DeLIVER programme for early liver cancer detection.
17 May 2023
The OxCODE members are two of eight Oxford researchers that have been elected to the Academy of Medical Sciences Fellowship.
6 April 2023
A team of researchers from the University of Oxford and the University of Nottingham have developed ‘CanPredict’, a new tool able to identify those most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and lives.
10 March 2023
Researchers and clinicians in Oxford have begun an evaluation of artificial intelligence (AI) software that could help pathologists diagnose prostate cancer.